KMTS

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.74
Percentage change -4.46	%

Held by: IWM IWO SCHA VTI FMED IWN VXF ONEQ BBSC SCHB

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.90	Insider Own	67.05%	Shs Outstand	51.35M	Perf Week	-10.20%
Market Cap	813.36M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	16.92M	Perf Month	-29.66%
Enterprise Value	1.10B	PEG	-	EPS next Q	-0.53	Inst Own	26.28%	Short Float	6.71%	Perf Quarter	-36.44%
Income	-95.07M	P/S	15.45	EPS this Y	-	Inst Trans	-4.71%	Short Ratio	4.94	Perf Half Y	-
Sales	52.64M	P/B	-	EPS next Y	-	ROA	-	Short Interest	1.14M	Perf YTD	-27.47%
Book/sh	-5.34	P/C	14.97	EPS next 5Y	-	ROE	-	52W High	26.15 -39.43%	Perf Year	-
Cash/sh	1.06	P/FCF	-	EPS past 3/5Y	- -	ROIC	-179.15%	52W Low	14.15 11.94%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	37.73%	Volatility	9.19% 8.79%	Perf 5Y	-
Dividend TTM	-	EV/Sales	20.94	EPS Y/Y TTM	-	Oper. Margin	-149.17%	ATR (14)	1.51	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.65	Sales Y/Y TTM	-	Profit Margin	-180.62%	RSI (14)	34.69	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	1.81	EPS Q/Q	-2.24%	SMA20	-11.80%	Beta	-	Target Price	27.50
Payout	-	Debt/Eq	7.22	Sales Q/Q	82.31%	SMA50	-25.13%	Rel Volume	2.02	Prev Close	16.58
Employees	-	LT Debt/Eq	7.22	Earnings	Jul 15 AMC	SMA200	-28.04%	Avg Volume	230.12K	Price	15.84
IPO	Mar 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	-107.19% 0.12%	Trades		Volume	465,571	Change	-4.46%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-25	Initiated	Wolfe Research	Outperform	$29
Mar-31-25	Initiated	Wells Fargo	Overweight	$28
Mar-31-25	Initiated	Stifel	Buy	$28
Mar-31-25	Initiated	Piper Sandler	Overweight	$27
Mar-31-25	Initiated	Goldman	Neutral	$24
Mar-31-25	Initiated	BofA Securities	Buy	$30

Jul-01-25 08:00AM	Kestra Medical Technologies, Ltd. to Report Fourth Quarter and Fiscal Year 2025 Results on July 15 (GlobeNewswire)
Jun-23-25 08:00AM	Kestra Medical Technologies Announces Inclusion in the Russell 2000 and Russell 3000 Indexes (GlobeNewswire) +6.45%
Jun-05-25 08:00AM	Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors (GlobeNewswire)
May-13-25 08:00AM	Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year 2025 Mountain West Award Finalist (GlobeNewswire)
Apr-30-25 08:00AM	Kestra Medical Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
08:00AM	Loading…
Apr-29-25 08:00AM	Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025 (GlobeNewswire)
Apr-23-25 08:00AM	Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025 (GlobeNewswire)
Apr-14-25 04:01PM	Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Apr-02-25 04:05PM	Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14 (GlobeNewswire) -6.54%
Mar-14-25 04:05PM	Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering (GlobeNewswire) +16.50%
Mar-07-25 05:30PM	Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering (GlobeNewswire)
Mar-05-25 11:03PM	Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)
Feb-26-25 08:00AM	Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering (GlobeNewswire)

Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Phillip D. Foshee in 2014 and is headquartered in Kirkland, WA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Kestra Medical Technologies Ltd

Upgrade your FINVIZ experience